Vaccine Development

Clinical Trials mRNA Technology COVID-19 Vaccines Regulatory Approval mRNA Vaccines Safety and Efficacy Vaccine Research Emergency Use Authorization Vaccine Safety Advisory Committees Research Funding Pharmaceutical Companies Vaccine Supply Biotechnology Vaccine Production Manufacturing Capacity Chikungunya Virus FDA Regulations Immunology Vaccine Effectiveness Immunization Regulatory Bodies Vaccine Hubs COVID-19 Regulatory Agencies Covid-19 Vaccines RNA Technology Immunization Programs Public Health Manufacturing Global Health Initiatives Ebola Vaccines Immunization Strategies

Engineered mRNA Nanoparticles Reroute Delivery to Lymph Nodes in Mouse Study

The Penn design cuts liver exposure about tenfold to support lower-dose, better-tolerated mRNA vaccines.

AI Pinpoints Single-Protein Mpox Target That Elicits Neutralizing Antibodies in Mice

Florida Starts Process to Drop Four School Vaccine Requirements

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine